Log in

NASDAQ:ATECAlphatec Stock Price, Forecast & News

$6.76
+0.65 (+10.64 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.82
Now: $6.76
$6.94
50-Day Range
$4.40
MA: $4.90
$6.11
52-Week Range
$2.19
Now: $6.76
$7.93
Volume1.33 million shs
Average Volume306,904 shs
Market Capitalization$432.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.92
Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, and Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody Systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Read More
Alphatec logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$113.43 million
Book Value$0.71 per share

Profitability

Net Income$-57,000,000.00

Miscellaneous

Employees195
Market Cap$432.98 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$6.76
+0.65 (+10.64 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alphatec (NASDAQ:ATEC) Frequently Asked Questions

How has Alphatec's stock been impacted by COVID-19 (Coronavirus)?

Alphatec's stock was trading at $4.41 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ATEC stock has increased by 53.3% and is now trading at $6.76.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Alphatec?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Alphatec
.

When is Alphatec's next earnings date?

Alphatec is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Alphatec
.

How were Alphatec's earnings last quarter?

Alphatec Holdings Inc (NASDAQ:ATEC) announced its quarterly earnings data on Thursday, August, 6th. The medical technology company reported ($0.25) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.29) by $0.04. Alphatec had a negative net margin of 54.42% and a negative return on equity of 167.29%.
View Alphatec's earnings history
.

What price target have analysts set for ATEC?

5 Wall Street analysts have issued 1 year price objectives for Alphatec's stock. Their forecasts range from $7.50 to $15.00. On average, they expect Alphatec's share price to reach $9.90 in the next year. This suggests a possible upside of 46.4% from the stock's current price.
View analysts' price targets for Alphatec
.

Has Alphatec been receiving favorable news coverage?

Media coverage about ATEC stock has been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Alphatec earned a news impact score of -2.0 on InfoTrie's scale. They also assigned news articles about the medical technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.
View the latest news about Alphatec
.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the following people:
  • Mr. Patrick S. Miles, Exec. Chairman & CEO (Age 53)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 55)
  • Mr. Terry M. Rich, Consultant (Age 51)
  • Mr. Jeffrey P. Rydin, Director (Age 52)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 50)

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (1.87%), Russell Investments Group Ltd. (0.75%), Creative Planning (0.06%), SG Americas Securities LLC (0.04%) and IFP Advisors Inc (0.02%). Company insiders that own Alphatec stock include Craig E Hunsaker, David Sponsel, Evan Bakst, James L L Tullis, Jeffrey G Black, Jeffrey P Rydin and Kelli Mari Howell.
View institutional ownership trends for Alphatec
.

Which institutional investors are buying Alphatec stock?

ATEC stock was acquired by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Russell Investments Group Ltd., Creative Planning, SG Americas Securities LLC, and IFP Advisors Inc. Company insiders that have bought Alphatec stock in the last two years include David Sponsel, Evan Bakst, and Kelli Mari Howell.
View insider buying and selling activity for Alphatec
.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $6.76.

How big of a company is Alphatec?

Alphatec has a market capitalization of $432.98 million and generates $113.43 million in revenue each year. The medical technology company earns $-57,000,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Alphatec employs 195 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is www.atecspine.com.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.